592 related articles for article (PubMed ID: 11797073)
21. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
[TBL] [Abstract][Full Text] [Related]
22. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
Butler GK; Montgomery AM
Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
[TBL] [Abstract][Full Text] [Related]
23. Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.
Turner JJ; Parrott AC; Goodwin J; Moore DG; Fulton S; Min MO; Singer LT
J Psychopharmacol; 2014 Jan; 28(1):55-61. PubMed ID: 24327452
[TBL] [Abstract][Full Text] [Related]
24. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
25. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Fox HC; Parrott AC; Turner JJ
J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
[TBL] [Abstract][Full Text] [Related]
26. Modelling the adverse effects associated with ecstasy use.
Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
[TBL] [Abstract][Full Text] [Related]
27. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Taurah L; Chandler C; Sanders G
Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
[TBL] [Abstract][Full Text] [Related]
28. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
29. Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study.
May AL; Parrott AC
Hum Psychopharmacol; 2015 Jul; 30(4):272-5. PubMed ID: 26216562
[TBL] [Abstract][Full Text] [Related]
30. Self-reported psychopathology in polydrug users.
Sumnall HR; Wagstaff GF; Cole JC
J Psychopharmacol; 2004 Mar; 18(1):75-82. PubMed ID: 15107188
[TBL] [Abstract][Full Text] [Related]
31. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
[TBL] [Abstract][Full Text] [Related]
32. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
Cowan RL; Lyoo IK; Sung SM; Ahn KH; Kim MJ; Hwang J; Haga E; Vimal RL; Lukas SE; Renshaw PF
Drug Alcohol Depend; 2003 Dec; 72(3):225-35. PubMed ID: 14643939
[TBL] [Abstract][Full Text] [Related]
33. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
34. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
35. [Psychiatric and cognitive long-term effects of ecstasy].
Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
[TBL] [Abstract][Full Text] [Related]
36. Relationship between ecstasy use and depression: a study controlling for poly-drug use.
Roiser JP; Sahakian BJ
Psychopharmacology (Berl); 2004 May; 173(3-4):411-7. PubMed ID: 14652710
[TBL] [Abstract][Full Text] [Related]
37. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
[TBL] [Abstract][Full Text] [Related]
38. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
Schifano F; Di Furia L; Forza G; Minicuci N; Bricolo R
Drug Alcohol Depend; 1998 Sep; 52(1):85-90. PubMed ID: 9788011
[TBL] [Abstract][Full Text] [Related]
39. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
Potter A; Downey L; Stough C
Curr Drug Abuse Rev; 2013 Mar; 6(1):71-6. PubMed ID: 23259912
[TBL] [Abstract][Full Text] [Related]
40. Everyday memory deficits in ecstasy-polydrug users.
Montgomery C; Fisk JE
J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
